B7-H3 Becomes The Hottest Antigen In Oncology, And One NK Engager Enters Clinic

/PRNewswire/ -- USA News Group News Commentary - For more than two decades, B7-H3 sat on the shortlist of theoretically perfect cancer drug targets that nobody